Cargando…

Rapid Detection of Actinobacillus pleuropneumoniae From Clinical Samples Using Recombinase Polymerase Amplification

Actinobacillus pleuropneumoniae (APP) is the causative agent of porcine pleuropneumonia, resulting in high economic impact worldwide. There are currently 19 known serovars of APP, with different ones being predominant in specific geographic regions. Outbreaks of pleuropneumonia, characterized by sud...

Descripción completa

Detalles Bibliográficos
Autores principales: Stringer, Oliver W., Li, Yanwen, Bossé, Janine T., Forrest, Matthew S., Hernandez-Garcia, Juan, Tucker, Alexander W., Nunes, Tiago, Costa, Francisco, Mortensen, Preben, Velazquez, Eduardo, Penny, Paul, Rodriguez-Manzano, Jesus, Georgiou, Pantelis, Langford, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990124/
https://www.ncbi.nlm.nih.gov/pubmed/35400111
http://dx.doi.org/10.3389/fvets.2022.805382
_version_ 1784683317621161984
author Stringer, Oliver W.
Li, Yanwen
Bossé, Janine T.
Forrest, Matthew S.
Hernandez-Garcia, Juan
Tucker, Alexander W.
Nunes, Tiago
Costa, Francisco
Mortensen, Preben
Velazquez, Eduardo
Penny, Paul
Rodriguez-Manzano, Jesus
Georgiou, Pantelis
Langford, Paul R.
author_facet Stringer, Oliver W.
Li, Yanwen
Bossé, Janine T.
Forrest, Matthew S.
Hernandez-Garcia, Juan
Tucker, Alexander W.
Nunes, Tiago
Costa, Francisco
Mortensen, Preben
Velazquez, Eduardo
Penny, Paul
Rodriguez-Manzano, Jesus
Georgiou, Pantelis
Langford, Paul R.
author_sort Stringer, Oliver W.
collection PubMed
description Actinobacillus pleuropneumoniae (APP) is the causative agent of porcine pleuropneumonia, resulting in high economic impact worldwide. There are currently 19 known serovars of APP, with different ones being predominant in specific geographic regions. Outbreaks of pleuropneumonia, characterized by sudden respiratory difficulties and high mortality, can occur when infected pigs are brought into naïve herds, or by those carrying different serovars. Good biosecurity measures include regular diagnostic testing for surveillance purposes. Current gold standard diagnostic techniques lack sensitivity (bacterial culture), require expensive thermocycling machinery (PCR) and are time consuming (culture and PCR). Here we describe the development of an isothermal point-of-care diagnostic test - utilizing recombinase polymerase amplification (RPA) for the detection of APP, targeting the species-specific apxIVA gene. Our APP-RPA diagnostic test achieved a sensitivity of 10 copies/μL using a strain of APP serovar 8, which is the most prevalent serovar in the UK. Additionally, our APP-RPA assay achieved a clinical sensitivity and specificity of 84.3 and 100%, respectively, across 61 extracted clinical samples obtained from farms located in England and Portugal. Using a small subset (n = 14) of the lung tissue samples, we achieved a clinical sensitivity and specificity of 76.9 and 100%, respectively) using lung imprints made on FTA cards tested directly in the APP-RPA reaction. Our results demonstrate that our APP-RPA assay enables a suitable rapid and sensitive screening tool for this important veterinary pathogen.
format Online
Article
Text
id pubmed-8990124
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89901242022-04-09 Rapid Detection of Actinobacillus pleuropneumoniae From Clinical Samples Using Recombinase Polymerase Amplification Stringer, Oliver W. Li, Yanwen Bossé, Janine T. Forrest, Matthew S. Hernandez-Garcia, Juan Tucker, Alexander W. Nunes, Tiago Costa, Francisco Mortensen, Preben Velazquez, Eduardo Penny, Paul Rodriguez-Manzano, Jesus Georgiou, Pantelis Langford, Paul R. Front Vet Sci Veterinary Science Actinobacillus pleuropneumoniae (APP) is the causative agent of porcine pleuropneumonia, resulting in high economic impact worldwide. There are currently 19 known serovars of APP, with different ones being predominant in specific geographic regions. Outbreaks of pleuropneumonia, characterized by sudden respiratory difficulties and high mortality, can occur when infected pigs are brought into naïve herds, or by those carrying different serovars. Good biosecurity measures include regular diagnostic testing for surveillance purposes. Current gold standard diagnostic techniques lack sensitivity (bacterial culture), require expensive thermocycling machinery (PCR) and are time consuming (culture and PCR). Here we describe the development of an isothermal point-of-care diagnostic test - utilizing recombinase polymerase amplification (RPA) for the detection of APP, targeting the species-specific apxIVA gene. Our APP-RPA diagnostic test achieved a sensitivity of 10 copies/μL using a strain of APP serovar 8, which is the most prevalent serovar in the UK. Additionally, our APP-RPA assay achieved a clinical sensitivity and specificity of 84.3 and 100%, respectively, across 61 extracted clinical samples obtained from farms located in England and Portugal. Using a small subset (n = 14) of the lung tissue samples, we achieved a clinical sensitivity and specificity of 76.9 and 100%, respectively) using lung imprints made on FTA cards tested directly in the APP-RPA reaction. Our results demonstrate that our APP-RPA assay enables a suitable rapid and sensitive screening tool for this important veterinary pathogen. Frontiers Media S.A. 2022-03-25 /pmc/articles/PMC8990124/ /pubmed/35400111 http://dx.doi.org/10.3389/fvets.2022.805382 Text en Copyright © 2022 Stringer, Li, Bossé, Forrest, Hernandez-Garcia, Tucker, Nunes, Costa, Mortensen, Velazquez, Penny, Rodriguez-Manzano, Georgiou and Langford. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Stringer, Oliver W.
Li, Yanwen
Bossé, Janine T.
Forrest, Matthew S.
Hernandez-Garcia, Juan
Tucker, Alexander W.
Nunes, Tiago
Costa, Francisco
Mortensen, Preben
Velazquez, Eduardo
Penny, Paul
Rodriguez-Manzano, Jesus
Georgiou, Pantelis
Langford, Paul R.
Rapid Detection of Actinobacillus pleuropneumoniae From Clinical Samples Using Recombinase Polymerase Amplification
title Rapid Detection of Actinobacillus pleuropneumoniae From Clinical Samples Using Recombinase Polymerase Amplification
title_full Rapid Detection of Actinobacillus pleuropneumoniae From Clinical Samples Using Recombinase Polymerase Amplification
title_fullStr Rapid Detection of Actinobacillus pleuropneumoniae From Clinical Samples Using Recombinase Polymerase Amplification
title_full_unstemmed Rapid Detection of Actinobacillus pleuropneumoniae From Clinical Samples Using Recombinase Polymerase Amplification
title_short Rapid Detection of Actinobacillus pleuropneumoniae From Clinical Samples Using Recombinase Polymerase Amplification
title_sort rapid detection of actinobacillus pleuropneumoniae from clinical samples using recombinase polymerase amplification
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990124/
https://www.ncbi.nlm.nih.gov/pubmed/35400111
http://dx.doi.org/10.3389/fvets.2022.805382
work_keys_str_mv AT stringeroliverw rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT liyanwen rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT bossejaninet rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT forrestmatthews rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT hernandezgarciajuan rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT tuckeralexanderw rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT nunestiago rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT costafrancisco rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT mortensenpreben rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT velazquezeduardo rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT pennypaul rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT rodriguezmanzanojesus rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT georgioupantelis rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification
AT langfordpaulr rapiddetectionofactinobacilluspleuropneumoniaefromclinicalsamplesusingrecombinasepolymeraseamplification